• 1. Distinctive size effects of Pt nanoparticles immobilized on Fe3O4@PPy used as an efficient recyclable catalyst for benzylic alcohol aerobic oxidation and hydrogenation reduction of nitroaromatics
  Yu Long,Bing Yuan,Jianrui Niu,Xin Tong,Jiantai Ma New J. Chem., 2015,39, 1179-1185
• 2. Evolution of hierarchical porous structures in supramolecular guest–host hydrogels?
  Christopher B. Rodell,Christopher B. Highley,Minna H. Chen,Neville N. Dusaj,Chao Wang,Lin Han,Jason A. Burdick Soft Matter, 2016,12, 7839-7847
• 3. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 4. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
• 5. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696

Introduction to α-L-Fucose-1-phosphate Di(cyclohexylammonium) Salt (CAS No. 24333-03-7)

The compound α-L-Fucose-1-phosphate Di(cyclohexylammonium) Salt, identified by its CAS number 24333-03-7, is a specialized chemical entity that has garnered significant attention in the field of biochemical research and pharmaceutical development. This compound, characterized by its unique structural and functional properties, plays a crucial role in various biological pathways and has potential applications in therapeutic interventions.

α-L-Fucose-1-phosphate is a derivative of fucose, a monosaccharide that is rarely found in nature but is highly abundant in certain glycoproteins and glycolipids. The phosphate group attached to the fucose molecule enhances its reactivity, making it a valuable intermediate in synthetic biology and drug design. The di(cyclohexylammonium) salt formulation further modifies the compound's solubility and stability, facilitating its use in aqueous environments and enhancing its bioavailability.

In recent years, there has been a surge in research focused on the role of fucosylated glycans in various biological processes. These glycans are known to be involved in cell signaling, immune responses, and pathogen recognition. The study of α-L-Fucose-1-phosphate has provided insights into the mechanisms by which these glycans modulate biological functions. For instance, research has demonstrated that fucosylation can influence the activity of certain enzymes and receptors, thereby affecting cellular communication and metabolic pathways.

The pharmaceutical industry has been particularly interested in leveraging the properties of α-L-Fucose-1-phosphate Di(cyclohexylammonium) Salt for the development of novel therapeutic agents. One area of focus has been its potential use as an immunomodulatory agent. Studies have shown that fucosylated compounds can modulate immune responses by interacting with specific receptors on immune cells. This has led to the exploration of α-L-Fucose-1-phosphate as a candidate for treating autoimmune diseases and enhancing vaccine efficacy.

Furthermore, the compound's structural properties make it a valuable tool in synthetic chemistry. The phosphate group provides a site for further chemical modification, allowing researchers to design complex molecules with tailored biological activities. This flexibility has been exploited in the development of glycosidase inhibitors, which are essential for treating diseases caused by glycosylation disorders. The di(cyclohexylammonium) salt form enhances the compound's stability during storage and transportation, making it more practical for industrial applications.

The latest research findings have highlighted the importance of α-L-Fucose-1-phosphate Di(cyclohexylammonium) Salt in understanding cellular processes at the molecular level. Advanced techniques such as mass spectrometry and nuclear magnetic resonance (NMR) spectroscopy have enabled scientists to elucidate the structure-function relationships of fucosylated glycans. These studies have revealed that subtle modifications in the structure of α-L-Fucose-1-phosphate can significantly alter its biological activity, providing new avenues for drug discovery.

In conclusion, α-L-Fucose-1-phosphate Di(cyclohexylammonium) Salt (CAS No. 24333-03-7) is a multifaceted compound with significant implications in biochemical research and pharmaceutical development. Its unique properties make it a valuable tool for studying glycosylation mechanisms and developing novel therapeutic agents. As research continues to uncover new applications for this compound, its importance in advancing our understanding of biological processes and improving human health is undeniable.

• 58459-37-3(D-Ribose 1-Phosphate, Biscyclohexylammonium Salt)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)